← Eichor
Study identifier: NCT07004673 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

18F FDG and 68Ga FAPI PET/MR Imaging of Carotid Artery Plaque Vulnerability: A Clinical Study in Carotid Artery Plaque Patients

Condition: Carotid Artery Plaque · Ischemic Stroke · PET / MR  ·  Sponsor: Ruijin Hospital

PhaseN/A
Planned participants100
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Carotid atherosclerotic plaque rupture is the main cause of ischemic stroke attacks, and early and precise assessment of plaque vulnerability can prevent ischemic stroke. High-resolution MRI can reflect vulnerable plaque features such as thin fibrous caps and large lipid cores, but cannot assess their metabolic information; Fibro-activated proteins (FAPs) of PET are specifically expressed in atherosclerosis and suggest vulnerable plaques by reflecting inflammation-induced fibrosis. The aim of this study was to apply 18F FDG\&68Ga-FAPI PET/MR imaging to investigate the vulnerability of carotid atherosclerotic plaques, to obtain quantitative evaluation indexes of active fibrosis within carotid plaques, and to clarify the PET/MR characteristics of unstable plaques in carotid arteries

This description comes directly from the study's public registry record.

Talk to the study team

JUN LIU Professor  ·  +86-021-64370045  ·  lj11128@rjh.com.cn

BIN LIU PhD student  ·  +86-021-64370045  ·  ousi@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Department of neurology, Ruijin Hospital, Shanghai Jiao Tong University School of MedicineShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07004673